An early stage startup providing healthcare solutions that enable personalized management of obesity and other chronic diseases.
Location: United States
Employees: 11-50
Phone: +1 877-673-0981
Total raised: $8.8M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Southeast ... | semncapita... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.05.2024 | - | $7.8M | - |
| 29.11.2018 | Seed | $1M | - |
Mentions in press and media 15
| Date | Title | Description |
| 08.04.2025 | Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response Using Precision Obesity Test | Source: MyPhenome genetic obesity test What You Should Know: – Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical... |
| 08.08.2024 | The Rise of Startups and the Demand for Personalized Care: A New Era in Innovation and Health | In the bustling world of innovation, startups are the new gladiators. They enter the arena with fresh ideas, ready to disrupt the status quo. Recently, five startups were awarded the SEF.Growth High Potential Label by the Swiss Economic For... |
| 07.08.2024 | Patients Demand Personalized Obesity Care, New Survey Finds | What You Should Know: – Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care. – The survey of 475 patients explored attitudes toward weig... |
| 17.05.2024 | Revolutionizing Obesity Treatment with Precision Medicine | Phenomix Sciences, a cutting-edge biotechnology company, has secured a whopping $7.8 million in funding to accelerate the adoption of precision medicine in the treatment of obesity. This influx of capital, including $5.5 million in Series A... |
| 16.05.2024 | Phenomix Sciences Raises $7.8M in Funding | Phenomix Sciences, a Menlo Park, Calif.-based precision medicine biotechnology company that brings data intelligence to the treatment of obesity, raised $7.8m in funding. The round included $5.5m in Series A funding from new investors DexCo... |
| 16.05.2024 | Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption | What You Should Know: – Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and La... |
| 04.04.2024 | Phenomix Sciences Launches 3-in-1 Obesity Phenotyping Test | What You Should Know: – Phenomix Sciences, a leader in precision medicine for obesity, launches a new MyPhenome test that identifies all three key obesity phenotypes in a single test. – The new test identifies all three of the company’s sig... |
| 30.03.2023 | Phenomix Sciences Launches Saliva Test to Predict Obesity Phenotype | What You Should Know: – Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of its first therapy selection test, the My Phenome Hungr... |
| 27.05.2022 | Phenomix Sciences Launches Obesity Biobanking Registry Studying Personalized Treatment Options Based on Genetics | What You Should Know: – Biotech company Phenomix Sciences launches its biobanking registry, marking the first obesity registry to study the impact of personalized treatment based on phenotyping. The impact of this biobanking registry and th... |
| 21.04.2021 | Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices | What You Should Know: – Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patie... |
Show more